Connection

RICHARD BOND to Male

This is a "connection" page, showing publications RICHARD BOND has written about Male.
Connection Strength

0.195
  1. Effects of ?-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype. Pulm Pharmacol Ther. 2017 Oct; 46:30-40.
    View in: PubMed
    Score: 0.023
  2. Differences in asthma study models and the effectiveness of ?2 -adrenoceptor ligands: response to Lipworth et al. Br J Pharmacol. 2016 Jan; 173(1):250-1.
    View in: PubMed
    Score: 0.021
  3. The intrinsic bias of generalizations. Am J Respir Crit Care Med. 2014 Feb 01; 189(3):359.
    View in: PubMed
    Score: 0.018
  4. Response to salbutamol in patients with mild asthma treated with nadolol. Eur Respir J. 2010 Oct; 36(4):963-5.
    View in: PubMed
    Score: 0.015
  5. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol. 2008 Mar; 38(3):256-62.
    View in: PubMed
    Score: 0.012
  6. The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther. 2008; 21(1):134-41.
    View in: PubMed
    Score: 0.012
  7. Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther. 2008; 21(1):115-24.
    View in: PubMed
    Score: 0.012
  8. Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery. Br J Pharmacol. 2003 Apr; 138(8):1505-16.
    View in: PubMed
    Score: 0.009
  9. The effects of ?1 and ?1+2 adrenergic receptor blockade on the exercise-induced mobilization and ex vivo expansion of virus-specific T cells: implications for cellular therapy and the anti-viral immune effects of exercise. Cell Stress Chaperones. 2020 11; 25(6):993-1012.
    View in: PubMed
    Score: 0.007
  10. Protective effect of propranolol and nadolol on social defeat-induced behavioral impairments in rats. Neurosci Lett. 2020 04 23; 725:134892.
    View in: PubMed
    Score: 0.007
  11. Systemic ?-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of V?9Vd2 T-Cells. Front Immunol. 2019; 10:3082.
    View in: PubMed
    Score: 0.007
  12. ?2-Adrenergic receptor signaling mediates the preferential mobilization of differentiated subsets of CD8+ T-cells, NK-cells and non-classical monocytes in response to acute exercise in humans. Brain Behav Immun. 2018 11; 74:143-153.
    View in: PubMed
    Score: 0.006
  13. Vigorous exercise mobilizes CD34+ hematopoietic stem cells to peripheral blood via the ?2-adrenergic receptor. Brain Behav Immun. 2018 02; 68:66-75.
    View in: PubMed
    Score: 0.006
  14. ?-Blockers have differential effects on the murine asthma phenotype. Br J Pharmacol. 2015 Oct; 172(20):4833-46.
    View in: PubMed
    Score: 0.005
  15. Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer. Cancer Res. 2014 Oct 01; 74(19):5631-43.
    View in: PubMed
    Score: 0.005
  16. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6997-7002.
    View in: PubMed
    Score: 0.004
  17. Interaction of tertatolol at the "atypical" or beta 3-adrenoceptor in guinea-pig ileum. Gen Pharmacol. 1992 Mar; 23(2):171-6.
    View in: PubMed
    Score: 0.004
  18. Partial agonistic activity of GR43175 at the inhibitory prejunctional 5-HT1-like receptor in rat kidney. J Auton Pharmacol. 1989 Jun; 9(3):201-10.
    View in: PubMed
    Score: 0.003
  19. Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation. J Pharmacol Exp Ther. 1989 May; 249(2):401-10.
    View in: PubMed
    Score: 0.003
  20. Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes. Br J Pharmacol. 1988 Nov; 95(3):723-34.
    View in: PubMed
    Score: 0.003
  21. Evidence for a receptor mediated action of norepinephrine distinct from alpha- and beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov; 334(3):261-6.
    View in: PubMed
    Score: 0.003
  22. Responses to norepinephrine resistant to inhibition by alpha and beta adrenoceptor antagonists. J Pharmacol Exp Ther. 1986 Feb; 236(2):408-15.
    View in: PubMed
    Score: 0.003
  23. Potentiation of endothelium-dependent hyperpolarization to serotonin by dietary intake of NC 020, a defined fish oil, in the porcine coronary artery. J Cardiovasc Pharmacol. 1995 Nov; 26(5):679-81.
    View in: PubMed
    Score: 0.001
  24. Marked enhancement in myocardial function resulting from overexpression of a human beta-adrenergic receptor gene. J Thorac Cardiovasc Surg. 1995 Feb; 109(2):236-41.
    View in: PubMed
    Score: 0.001
  25. The sydnonimine C87-3754 evokes endothelium-independent relaxations and prevents endothelium-dependent contractions in blood vessels of the dog. J Cardiovasc Pharmacol. 1993; 22 Suppl 7:S10-6.
    View in: PubMed
    Score: 0.001
  26. Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. J Cardiovasc Pharmacol. 1991 Jun; 17(6):964-9.
    View in: PubMed
    Score: 0.001
  27. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol. J Pharmacol Exp Ther. 1990 Mar; 252(3):1034-42.
    View in: PubMed
    Score: 0.001
  28. An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan; 332(1):8-15.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.